2024 perioperative management glp-1 receptor agonists anesthesia and delayed gastric emptying: Another opportunity to use gastric ultrasound prior to the induction of general Anesthetic Considerations for Patients Taking
Description
GLP-1R agonist 2 has the potential for research in metabolic diseases such as type 2 diabetes and obesity
Reduced risk of side effects
For people who stopped taking GLP-1 weight-loss medications, patients regained about 60% of the weight []
This does not influence our rankings or medical evaluations
Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone
Not for human or veterinary use
